Contract Pharmaceutical Manufacturing, Research, and Packaging

  • Published: August 2007
  • |
  • Report Code: PHM043B


  • Worldwide revenue for contract manufacture of prescription drugs (dosage forms) for 2004 was $11.1 billion, which is projected to increase at a compound annual growth rate (CAGR) of 9.4%, reaching $22.5 billion by the end of 2011.
  • Contract manufacture of over-the-counter and nutritional products worldwide is projected to reach $108.8 billion by 2011 increasing at a CAGR of 8.1%. Contract research revenues are projected to reach $24.3 billion by 2011, increasing from $17.3 billion in 2006 at a CAGR of 7.0%.
  • Contract manufacturing in the bulk drug market had worldwide revenue of about $13.5 billion in 2004.

Download Free Chapter



BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contract manufacturing, research, and packaging in the pharmaceutical business. The key objective is to present a comprehensive analysis of the current market and its future direction in the pharmaceutical outsourcing industry with the emphasis on contract manufacturing.

This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceutical industry. Definitions, needs, requirements, and the advantages and disadvantages of outsourcing are discussed. The study also includes market forecasts and a discussion of the market leaders in the industry. Risks involved, regulatory requirements, and technologies involved are crucial components of this market outlook.

Influential market scenarios such as the need for contract manufacturing, research, selection of contractors, etc. have been included, along with a detailed analysis of the pharmaceutical/biopharmaceutical contract manufacturing, research, and packaging industry structure. Revenues are broken down by the bulk as well as by dosage forms of solid, liquid, and semisolid. Sales figures are estimated for the 5-year period from 2006 through 2011.

Over-the-counter (OTC), nutritional, and drug delivery products are discussed separately in this report. Contract research and contract packaging are also discussed separately


This report contains:

  • The current market status for contract manufacturing, research, and packaging and forecasts for growth through 2011
  • Discussion of the advantages and disadvantages of outsourcing
  • Technological issues including the latest trends and developments
  • Descriptions of each market's need for outsourcing, risks and regulatory environment.
  • A break down of revenues by the bulk as well as by the dosage forms of solid, liquid and semisolid.


BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical and contracting experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.


Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing/research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.


Shalini Shahani holds a master's degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shahani was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.

Download Free Chapter


Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to
  Title/Chapter Name Pages Price
Contract Pharmaceutical Manufacturing, Research, and Packaging 181 $2660
Chapter- 1: INTRODUCTION - Complimentary 3 $0
  Show Details
Chapter- 2: SUMMARY - Complimentary 1 $0
  Show Details
Chapter- 3: OVERVIEW 11 $242
  Show Details
Chapter- 4: TECHNOLOGY 10 $220
  Show Details
Chapter- 5: REGULATORY ASPECTS 4 $88
  Show Details
Chapter- 6: INDUSTRY STRUCTURE 21 $463
  Show Details
Chapter- 7: NEW DEVELOPMENTS 5 $110
  Show Details
Chapter- 8: MARKETS 65 $1433
  Show Details
  Show Details
Chapter- 10: PATENT ANALYSIS 10 $220
  Show Details
Chapter- 11: CURRENT ENVIRONMENT 5 $110
  Show Details
Chapter- 12: COMPANY PROFILES 32 $705
  Show Details
  Show Details
  List of Tables
  List of Figures

Also See
PHM043A - May 2005

Upcoming Report
PHM043G - May 2017

Latest Version
PHM043F - June 2015

download free chapter
Select License type:

Original Price $6650
Special Price $2660

buy now

Preferred Pricing available for:

  • Startup or Small Business (Revenue <$1M)
  • Academic Institute
  • Government Agency
  • Nonprofit Organization
Get Started
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports